HVAX Technologies, an India-based turnkey integrated pharma factory specialist, is now a publicly listed company following an initial public offering (IPO).
An IPO is the process of a private company initially selling shares of stock to the public and the company's ownership transitioning from private ownership to public ownership.
The company is a specialist in controlled environments and cleanrooms. Over the years it has built biotech facilities, hospitals, and predominantly pharmaceutical facilities, in over 15 countries across the globe.
Over the last year few years HVAX has built on its strengths and internalised manufacturing of critical components which has helped set up strong infrastructure for clients, driving innovation to improve what they innovate.
This IPO is not just our achievement; it’s a shared victory for every individual who has been a part of our story
"This IPO is not just our achievement; it’s a shared victory for every individual who has been a part of our story,” HVAX Technologies," said in a LinkedIn post.
According to HVAX Technologies’ LinkedIn post, the transition from a private company to a public company enables it to enhance its services in the following ways:
Enhance services - A public listing will enable HVAX Technologies to invest in advanced resources and technologies, delivering top-quality products, improving employee experiences, and strengthening the vendor network.
Greater transparency - As a Public Limited Company, HVAX can uphold the highest standards of transparency and accountability fostering greater confidence in operations and ethical practices.
More opportunities - This transition unlocks new markets and partnerships, enhancing customer relationships, supporting employee growth, and deepening vendor collaborations.
